Table 2 Results of the community survey conducted on May 6–7, 2020 and associations with PCR positivity in Qatar.
From: Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Characteristics | Original sample size | SARS-CoV-2 positive* | Univariable regression analysis | Multivariable regression analysis | |||
---|---|---|---|---|---|---|---|
N (%) | N (%†) | p value | OR (95% CI)‡ | p value§ | AOR (95% CI)‡ | p value¶ | |
Socio-demographic characteristics | |||||||
Sex | |||||||
Females | 272 (20.8) | 21 (10.6) | 0.318 | 1.00 | – | – | |
Males | 1,035 (79.2) | 135 (15.9) | 1.59 (0.64–3.97) | 0.322 | – | – | |
Age (years) | |||||||
< 30 | 320 (24.5) | 41 (13.7) | 0.811 | 1.00 | – | – | |
30–39 | 534 (40.9) | 76 (15.9) | 1.19 (0.64–2.24) | 0.582 | – | – | |
40–49 | 264 (20.2) | 28 (17.3) | 1.32 (0.53–3.30) | 0.549 | – | – | |
50 + | 189 (14.5) | 11 (10.5) | 0.74 (0.18–3.07) | 0.679 | – | – | |
Nationality | |||||||
All other nationalities# | 255 (19.5) | 16 (6.2) | 0.019 | 1.00 | 1.00 | ||
Indian | 531 (40.6) | 86 (17.4) | 3.18 (1.80–5.64) | < 0.001 | 2.61 (1.20–5.68) | 0.016 | |
Filipino | 116 (8.9) | 19 (17.4) | 3.18 (1.53–6.60) | 0.002 | 3.23 (1.28–8.14) | 0.013 | |
Sri Lankan | 32 (2.5) | 10 (33.4) | 7.56 (2.96–19.32) | < 0.001 | 5.76 (1.88–17.63) | 0.002 | |
Egyptian | 90 (6.9) | 7 (8.5) | 1.40 (0.55–3.60) | 0.481 | 1.80 (0.64–5.04) | 0.265 | |
Nepalese | 27 (2.1) | 6 (24.6) | 4.92 (1.67–14.53) | 0.004 | 5.21 (1.54–17.55) | 0.008 | |
Bangladeshi | 14 (1.1) | 3 (21.2) | 4.06 (0.99–16.57) | 0.051 | 1.66 (0.46–6.00) | 0.441 | |
Pakistani | 23 (1.8) | 4 (17.3) | 3.16 (0.93–10.73) | 0.066 | 2.37 (0.53–10.62) | 0.259 | |
Sudanese | 20 (1.5) | 2 (12.4) | 2.14 (0.43–10.55) | 0.351 | 2.10 (0.51–8.72) | 0.306 | |
Qatari | 199 (15.2) | 3 (1.9) | 0.29 (0.08–1.09) | 0.068 | 0.37 (0.10–1.40) | 0.141 | |
Educational attainment | |||||||
Bachelor’s degree | 511 (39.1) | 52 (10.7) | 0.038 | 1.00 | 1.00 | ||
High school | 440 (33.7) | 59 (13.7) | 1.34 (0.73–2.44) | 0.346 | 1.17 (0.60–2.28) | 0.645 | |
Post-graduate studies | 118 (9.0) | 16 (30.5) | 3.68 (1.41–9.57) | 0.008 | 5.36 (2.29–12.56) | < 0.001 | |
Unknown | 238 (18.2) | 29 (15.1) | 1.50 (0.70–3.21) | 0.299 | 0.70 (0.21–2.38) | 0.571 | |
Occupation** | |||||||
Healthcare | 48 (3.7) | 2 (1.8) | 0.011 | 1.00 | 1.00 | ||
Aviation/Police/Government | 57 (4.4) | 8 (22.4) | 15.67 (2.51–97.89) | 0.003 | 18.82 (2.46–144.22) | 0.005 | |
Hospitality/Retail/Education | 118 (9.0) | 6 (3.8) | 2.16 (0.38–12.14) | 0.381 | 1.51 (0.18–12.39) | 0.703 | |
Professional/Office | 292 (22.3) | 26 (10.2) | 6.17 (1.28–29.78) | 0.024 | 6.82 (1.10–42.18) | 0.039 | |
Transportation/driver | 98 (7.5) | 17 (28.7) | 21.82 (3.98–119.60) | < 0.001 | 15.04 (2.22–101.73) | 0.005 | |
Construction/Blue collar jobs | 213 (16.3) | 37 (18.4) | 12.18 (2.41–61.52) | 0.003 | 11.95 (1.98–72.03) | 0.007 | |
Not employed | 141 (10.8) | 16 (9.2) | 5.46 (1.10–27.05) | 0.038 | 7.06 (0.98–50.66) | 0.052 | |
Unknown/Other | 340 (26.0) | 44 (17.1) | 11.14 (3.01–93.46) | 0.003 | 16.29 (2.50–106.31) | 0.004 | |
Study-related characteristics | |||||||
Study recruitment/invitation | |||||||
Invited/sampled | 268 (20.5) | 17 (10.9) | 0.441 | 1.00 | – | – | |
In same car/invited | 145 (11.1) | 20 (11.6) | 1.08 (0.37–3.15) | 0.894 | – | – | |
Not invited | 687 (52.6) | 92 (17.3) | 1.71 (0.63–4.63) | 0.292 | – | – | |
Unknown | 207 (15.8) | 27 (13.7) | 1.30 (0.44–3.80) | 0.636 | – | – | |
Primary Health Care Corporation center | |||||||
Leabib/Unknown | 304 (23.3) | 13 (6.5) | 0.075 | 1.00 | 1.00 | ||
Al-Thumama | 567 (43.4) | 86 (17.1) | 2.96 (1.00 -8.80) | 0.050 | 1.38 (0.41–4.65) | 0.601 | |
Al-Waab | 436 (33.4) | 57 (17.5) | 3.05 (1.05–8.89) | 0.041 | 2.10 (0.64–6.91) | 0.222 | |
Clinical characteristics | |||||||
Presence of symptoms | |||||||
No symptoms | 849 (65.0) | 72 (11.6) | < 0.001 | 1.00 | 1.00 | ||
One symptom | 139 (10.6) | 18 (19.4) | 1.84 (0.64–5.30) | 0.258 | 1.49 (0.61–3.68) | 0.382 | |
Two symptoms | 80 (6.1) | 19 (19.4) | 1.84 (0.75–4.47) | 0.180 | 2.28 (0.90–5.79) | 0.081 | |
Three or more symptoms | 68 (5.2) | 24 (50.3) | 7.73 (2.97–20.08) | < 0.001 | 6.04 (2.56–14.24) | < 0.001 | |
Unknown | 171 (13.1) | 23 (13.6) | 1.21 (0.58–2.53) | 0.620 | 1.04 (0.28–3.83) | 0.950 | |
Sought medical attention in the past 2 weeks | |||||||
No | 1,125 (86.1) | 130 (14.2) | < 0.001 | 1.00 | 1.00 | ||
Yes | 11 (0.8) | 3 (69.8) | 14.03 (2.15–91.51) | 0.006 | 9.84 (1.55–62.64) | 0.016 | |
Unknown | 171 (13.1) | 23 (13.6) | 0.96 (0.48–1.91) | 0.900 | Omitted | – | |
Hospitalized in the past 2 weeks | |||||||
No | 1,133 (99.7) | 132 (15.1) | 0.784 | 1.00 | – | – | |
Yes | 3 (0.3) | 1 (25.7) | 1.95 (0.17–22.02) | 0.590 | – | – | |
Unknown | 171 (13.1) | 23 (13.6) | 0.89 (0.44–1.78) | 0.738 | – | – | |
Contact with index case | |||||||
No | 750 (57.4) | 82 (15.2) | 0.961 | 1.00 | – | – | |
Yes | 281 (21.5) | 42 (14.9) | 0.98 (0.54–1.76) | 0.943 | – | – | |
Unknown (do not know) | 276 (21.1) | 32 (14.2) | 0.93 (0.44–1.94) | 0.844 | – | – | |
SARS-CoV-2 PCR positivity | |||||||
Test result | |||||||
Negative | 1,125 (86.1) | – | – | – | – | – | – |
Positive | 156 (11.9) | 156 (14.9) | – | – | – | – | – |
Inconclusive | 26 (2.0) | – | – | – | – | – | – |